Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Amortization - GoodwillEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares IssuedShares OutstandingWages, Salaries and Other
Ratios

Harvard Bioscience (HBIO) EBIAT (2016 - 2025)

Historic EBIAT for Harvard Bioscience (HBIO) over the last 17 years, with Q3 2025 value amounting to -$1.2 million.

  • Harvard Bioscience's EBIAT rose 7436.48% to -$1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$53.8 million, marking a year-over-year decrease of 27802.82%. This contributed to the annual value of -$12.4 million for FY2024, which is 26325.04% down from last year.
  • Harvard Bioscience's EBIAT amounted to -$1.2 million in Q3 2025, which was up 7436.48% from -$2.3 million recorded in Q2 2025.
  • In the past 5 years, Harvard Bioscience's EBIAT registered a high of $2.4 million during Q2 2022, and its lowest value of -$50.3 million during Q1 2025.
  • Moreover, its 5-year median value for EBIAT was -$1.2 million (2023), whereas its average is -$4.2 million.
  • Examining YoY changes over the last 5 years, Harvard Bioscience's EBIAT showed a top increase of 69390.24% in 2022 and a maximum decrease of 190294.12% in 2022.
  • Over the past 5 years, Harvard Bioscience's EBIAT (Quarter) stood at $961000.0 in 2021, then tumbled by 273.36% to -$1.7 million in 2022, then dropped by 9.12% to -$1.8 million in 2023, then surged by 100.99% to $18000.0 in 2024, then crashed by 6938.89% to -$1.2 million in 2025.
  • Its last three reported values are -$1.2 million in Q3 2025, -$2.3 million for Q2 2025, and -$50.3 million during Q1 2025.